Conformational landscape of the epidermal growth factor receptor kinase reveals a mutant specific allosteric pocket
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Conformational landscape of the epidermal growth factor receptor kinase reveals a mutant specific allosteric pocket
Authors
Keywords
-
Journal
Chemical Science
Volume 9, Issue 23, Pages 5212-5222
Publisher
Royal Society of Chemistry (RSC)
Online
2018-05-16
DOI
10.1039/c8sc01262h
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinib
- (2017) Srinivasaraghavan Kannan et al. Scientific Reports
- The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016
- (2016) Daniel S.W. Tan et al. Journal of Thoracic Oncology
- Review on EGFR Inhibitors: Critical Updates
- (2016) Davinder Singh et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
- (2016) Yong Jia et al. NATURE
- Analysis of different HER-2 mutations in breast cancer progression and drug resistance
- (2015) Zijia Sun et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- Conformational Transition Pathways of Epidermal Growth Factor Receptor Kinase Domain from Multiple Molecular Dynamics Simulations and Bayesian Clustering
- (2014) Yan Li et al. Journal of Chemical Theory and Computation
- The clinical development of MEK inhibitors
- (2014) Yujie Zhao et al. Nature Reviews Clinical Oncology
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- The free energy landscape in translational science: how can somatic mutations result in constitutive oncogenic activation?
- (2014) Chung-Jung Tsai et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Unraveling structural mechanisms of allosteric drug action
- (2014) Ruth Nussinov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Activation pathway of Src kinase reveals intermediate states as targets for drug design
- (2014) Diwakar Shukla et al. Nature Communications
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- (2014) D. A. E. Cross et al. Cancer Discovery
- Allostery in Disease and in Drug Discovery
- (2013) Ruth Nussinov et al. CELL
- Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase
- (2013) L. Sutto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transitions to catalytically inactive conformations in EGFR kinase
- (2013) Y. Shan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC
- (2013) A. O. Walter et al. Cancer Discovery
- Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
- (2012) Yibing Shan et al. CELL
- Mechanism of Drug Efficacy Within the EGF Receptor Revealed by Microsecond Molecular Dynamics Simulation
- (2012) S. Wan et al. MOLECULAR CANCER THERAPEUTICS
- The Epidermal Growth Factor Receptor-L861Q Mutation Increases Kinase Activity without Leading to Enhanced Sensitivity Toward Epidermal Growth Factor Receptor Kinase Inhibitors
- (2011) Rama Krishna Kancha et al. Journal of Thoracic Oncology
- The Energy Landscape Analysis of Cancer Mutations in Protein Kinases
- (2011) Anshuman Dixit et al. PLoS One
- Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations
- (2008) Egle Avizienyte et al. BIOCHEMICAL JOURNAL
- Activation of tyrosine kinases by mutation of the gatekeeper threonine
- (2008) Mohammad Azam et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- (2008) C.-H. Yun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started